Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,471 results for ""TOBRAMYCIN""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Zealand.

  • Authors : Larcombe R; University of South Australia, Adelaide, South Australia, Australia .; Flinders Medical Centre, Bedford Park, South Australia, Australia.

Subjects: Cystic Fibrosis*/Cystic Fibrosis*/Cystic Fibrosis*/drug therapy ; Tobramycin*/Tobramycin*/Tobramycin*/administration & dosage ; Tobramycin*/Tobramycin*/Tobramycin*/blood

  • Source: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2024 Jun 21; Vol. 31 (4), pp. 301-306. Date of Electronic Publication: 2024 Jun 21.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101578294 Publication Model: Electronic Cited Medium: Print ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Inhaled aztreonam lysine versus inhaled tobramycin in cystic fibrosis. An economic evaluation.

  • Authors : Schechter MS; 1 Department of Pediatrics, Division of Pulmonary Medicine, Virginia Commonwealth University and Children's Hospital of Richmond at VCU, Richmond, Virginia.; Trueman D

Subjects: Cost-Benefit Analysis*; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*economics ; Aztreonam/Aztreonam/Aztreonam/*economics

  • Source: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2015 Jul; Vol. 12 (7), pp. 1030-8.Publisher: American Thoracic Society Country of Publication: United States NLM ID: 101600811 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

Budget impact model of tobramycin inhalation solution for treatment of Pseudomonas aeruginosa in cystic fibrosis patients.

Subjects: Pseudomonas aeruginosa*; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*economics

  • Source: Journal of medical economics [J Med Econ] 2010; Vol. 13 (3), pp. 492-9.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print Cited Medium: Internet ISSN: 1941-837X

Record details

Read More Add to Saved list
×
Academic Journal

Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection.

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects; Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*complications

  • Source: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2012 Jan 15; Vol. 185 (2), pp. 171-8. Date of Electronic Publication: 2011 Nov 17.Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Tobramycin and Vancomycin in an In Vitro Model of Anterior Cruciate Ligament Allograft Decontamination.

Subjects: STAPHYLOCOCCAL disease prevention; DECONTAMINATION (From gases, chemicals, etc.); IN vitro studiesUNITED States

  • Source: American Journal of Sports Medicine; Mar2024, Vol. 52 Issue 4, p956-960, 5p

Record details

Read More Add to Saved list
×
Academic Journal

Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis.

  • Authors : Bilton D; Papworth Hospital, Adult CF Centre, Papworth Everard Cambridge, Cambridge CB38RE, UK. ; Henig N

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Bronchiectasis/Bronchiectasis/Bronchiectasis/*complications ; Bronchiectasis/Bronchiectasis/Bronchiectasis/*drug therapy

  • Source: Chest [Chest] 2006 Nov; Vol. 130 (5), pp. 1503-10.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis.

  • Authors : Geller DE; Nemours Children's Clinic, Division of Pulmonology, Orlando, FL 32806, USA. ; Pitlick WH

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy ; Tobramycin/Tobramycin/Tobramycin/*therapeutic use

  • Source: Chest [Chest] 2002 Jul; Vol. 122 (1), pp. 219-26.Publisher: Elsevier Country of Publication: United States NLM ID: 0231335 Publication Model: Print Cited Medium: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*mortality ; Pseudomonas Infections/Pseudomonas Infections/Pseudomonas Infections/*drug therapy

  • Source: Epidemiology (Cambridge, Mass.) [Epidemiology] 2003 Jan; Vol. 14 (1), pp. 55-9.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9009644 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
Academic Journal

A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis.

  • Authors : Van Meter DJ; Pharmacy Department, Fletcher Allen Health Care, Burlington, Vermont 05401, USA.; Corriveau M

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*administration & dosage ; Cystic Fibrosis/Cystic Fibrosis/Cystic Fibrosis/*drug therapy ; Drug Utilization/Drug Utilization/Drug Utilization/*statistics & numerical data

  • Source: Pediatric pulmonology [Pediatr Pulmonol] 2009 Apr; Vol. 44 (4), pp. 325-9.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8510590 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*therapeutic use ; Ciprofloxacin/Ciprofloxacin/Ciprofloxacin/*therapeutic use

  • Source: Archives of pediatrics & adolescent medicine [Arch Pediatr Adolesc Med] 2011 Sep; Vol. 165 (9), pp. 847-56.Publisher: American Medical Association Country of Publication: United States NLM ID: 9422751 Publication Model: Print Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  1,471 results for ""TOBRAMYCIN""